Evidence map›Paper›PMID 35028707›Full record

ArticleArchives of orthopaedic and trauma surgery2023

Spacer exchange in persistent periprosthetic joint infection: microbiological evaluation and survivorship analysis.

Antonio Clemente, Luca Cavagnaro, Antonio Russo, Francesco Chiarlone, Alessandro Massè, Giorgio Burastero

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of orthopaedic and trauma surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Search for Potentially VirulentInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Periprosthetic Joint Infection (PJI).The archives of bone and joint surgery · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Antonio ClementeDepartment of Orthopedics and Traumatology, C.T.O. Hospital, via G. Zuretti 29, 10126, Turin, Italy. antonioclemente.ort@gmail.com.ORCID http://orcid.org/0000-0002-0511-9639
Luca CavagnaroJoint Arthroplasty Unit, Orthopedic and Traumatology 2, Santa Corona Hospital, Viale XXV Aprile 38, Pietra Ligure, Italy.
Antonio RussoOrthopaedic Clinic, San Martino Hospital, Largo R. Benzi 10, 16132, Genoa, Italy.
Francesco ChiarloneJoint Arthroplasty Unit, Orthopedic and Traumatology 2, Santa Corona Hospital, Viale XXV Aprile 38, Pietra Ligure, Italy.
Alessandro MassèDepartment of Orthopedics and Traumatology, C.T.O. Hospital, via G. Zuretti 29, 10126, Turin, Italy.
Giorgio BurasteroProsthetic Surgery Centre, Galeazzi Orthopedic Institute, via R. Galeazzi 4, 20161, Milan, Italy.
CTO Hospital · ITOspedale Santa Corona · ITIstituto Ortopedico Galeazzi · ITOspedale Policlinico San Martino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purposes of this study were to determine demographics and characteristics of patients who underwent spacer exchange for persistent infection in the setting of two-stage arthroplasty for periprosthetic joint infection, to describe the microbiology of pathogens involved, to analyze survivorship free from infection in these patients.

methodsThe institutional prospectively collected database was reviewed to enroll patients with minimum 2 years follow-up. Patients who underwent two-stage procedure for septic arthritis were excluded, as were patients who had spacer fracture or dislocation.

resultsA total of 34 patients (41 procedures) were included. Mean age was 65.0 ± 12.8 years. Mean follow-up was 53.4 ± 24.8 months. Mean number of previous procedures was 3.6 ± 1.2. A total of 27 (79.4%) patients underwent final reimplantation. The most frequently isolated pathogen in spacer exchange was Staphylococcus epidermidis (10 cases, 28.6%). Polymicrobial cultures were obtained from 9 (25.71%) patients, 10 (28.6%) presented culture-negative infections. A total of 11 (32.4%) resistant pathogens were isolated, and 16 (47.0%) difficult to treat pathogens were detected. Eradication rate was 78.8%. Overall survivorship of implants after final reimplantation was 72.8% at 51.8 months.

conclusionSurgeons should be aware that subjects necessitating spacer exchange often present multiple comorbidities, previous staged revision failures, soft-tissue impairment and difficult to treat infection. In these patients, spacer exchange provides good clinical results and infection eradication, preventing arthrodesis or amputation.

Indexed as

Arthritis, InfectiousArthroplasty, Replacement, HipArthroplasty, Replacement, KneeProsthesis-Related InfectionsAgedAnti-Bacterial AgentsHumansMiddle AgedPersistent InfectionReoperationRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsBone infectionPeriprosthetic joint infectionTotal hip revisionTotal knee revision

Identifiers

PMID35028707
OpenAlexW4206669473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.